Canada markets close in 25 minutes
  • S&P/TSX

    20,373.19
    +85.39 (+0.42%)
     
  • S&P 500

    4,421.47
    +34.31 (+0.78%)
     
  • DOW

    35,103.46
    +265.30 (+0.76%)
     
  • CAD/USD

    0.7978
    -0.0019 (-0.24%)
     
  • CRUDE OIL

    70.60
    -0.66 (-0.93%)
     
  • BTC-CAD

    48,017.75
    -1,727.89 (-3.47%)
     
  • CMC Crypto 200

    934.32
    -9.13 (-0.97%)
     
  • GOLD FUTURES

    1,813.80
    -8.40 (-0.46%)
     
  • RUSSELL 2000

    2,219.88
    +4.38 (+0.20%)
     
  • 10-Yr Bond

    1.1760
    +0.0020 (+0.17%)
     
  • NASDAQ

    14,751.60
    +70.53 (+0.48%)
     
  • VOLATILITY

    17.76
    -1.70 (-8.74%)
     
  • FTSE

    7,105.72
    +24.00 (+0.34%)
     
  • NIKKEI 225

    27,641.83
    -139.19 (-0.50%)
     
  • CAD/EUR

    0.6720
    -0.0011 (-0.16%)
     

21 cases of Delta Plus COVID-19 variant found in seven districts: Maharashtra Health Minister

·1 min read
Maharashtra Health Minister Rajesh Tope  (Photo/ANI)
Maharashtra Health Minister Rajesh Tope (Photo/ANI)

Mumbai (Maharashtra) [India], June 23 (ANI): Maharashtra Health Minister Rajesh Tope on Wednesday said that 21 cases of Delta Plus variant of coronavirus have been found in seven districts of the state.

"Twenty-one cases of Delta Plus variant have been found in seven districts of the state. We are isolating such cases and taking all details like travel history, contact tracing and if they have been vaccinated," Tope told reporters.

"We have decided to send the samples for the genome sequence study. No deaths have been caused due to the Delta Plus variant. Symptoms and treatment are the same for this variant. No children have been infected with this variant," he added.

A total of 40 cases of Delta Plus variant of coronavirus has been detected in the country, government sources said on Wednesday, adding that most of the infections were from Maharashtra, Madhya Pradesh, Kerala, and Tamil Nadu.

According to Union Health Ministry, INSACOG (Indian SARS-CoV -2 Genomics Consortium) has informed that Delta Plus Variant is currently a "Variant of Concern (VOC)" and it has characteristics of increased transmissibility, stronger binding to receptors of lung cells and potential reduction in monoclonal antibody response.

Following the detection of the 'Delta Plus' variant in COVID patients in some parts of the country, the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) have decided to conduct a study to see if the new and more potent variant of coronavirus can be neutralised by the vaccine. (ANI)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting